ADMA Biologics Inc - Common Stock (ADMA)
15.87
-0.24 (-1.46%)
Adma Biologics is a biotechnology company that specializes in the development and manufacturing of immune globulin therapies and other biologics for patients suffering from immune deficiencies and specific infectious diseases
The company focuses on harnessing human plasma to create products that can improve immune response and provide critical support for individuals with compromised immune systems. Through its innovative research and commitment to quality, Adma aims to deliver safe and effective therapies that enhance patient outcomes and overall health.
Frequently Asked Questions
Is ADMA Biologics Inc - Common Stock publicly traded?
Yes, ADMA Biologics Inc - Common Stock is publicly traded.
What exchange does ADMA Biologics Inc - Common Stock trade on?
ADMA Biologics Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ADMA Biologics Inc - Common Stock?
The ticker symbol for ADMA Biologics Inc - Common Stock is ADMA on the Nasdaq Stock Market
What is the current price of ADMA Biologics Inc - Common Stock?
The current price of ADMA Biologics Inc - Common Stock is 15.87
When was ADMA Biologics Inc - Common Stock last traded?
The last trade of ADMA Biologics Inc - Common Stock was at 3:05 pm EST on January 31st, 2025
What is the market capitalization of ADMA Biologics Inc - Common Stock?
The market capitalization of ADMA Biologics Inc - Common Stock is 3.12B
How many shares of ADMA Biologics Inc - Common Stock are outstanding?
ADMA Biologics Inc - Common Stock has 196.36M shares outstanding.